http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007129403-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4180fc57a693864e2ce2dbfd64a9278 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate | 2006-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bf14e62ece7e142d8ad1646b7e007eb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_724d0f8f47fadb6ba8ccdb883aad55b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05198d41bb132e704d7bf73097bc437a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08fa9936373f15644525c05a2fb2a361 |
| publicationDate | 2007-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2007129403-A1 |
| titleOfInvention | Method of treating schizophrenia and/or glucoregulatory abnormalities |
| abstract | The present invention provides methods of treating schizophrenia and/or glucoregulatory abnormalities in a patient in need thereof comprising administering to said patient a therapeutically effective amount of a compound of formula I n nwherein in is 0, 1 or 2; n is 0, 1 or 2; p is 0 or 1; n each R is independently hydrogen, halogen, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, benzyloxy, hydroxy, nitro or amino; each R 1 is independently hydrogen, C 1 -C 6 alkyl, C 1 -C 6 alkenyl, C 1 -C 6 alkanoyl, halogen, cyano, —C(O)C 1 -C 6 alkyl, —C 1 -C 6 alkyleneCN, —C 1 -C 6 alkyleneNR′R″ wherein R′ and R″ are each independently hydrogen or C 1 -C 6 alkyl, —C 1 -C 6 alkyleneOC(O)C 1 -C 6 alkyl, or —CH(OH)R 4 wherein R 4 is hydrogen or C 1 -C 6 alkyl; R 2 is hydrogen, C 1 -C 6 alkyl optionally substituted with halogen, hydroxy or benlzyloxy, C 1 -C 6 alkenyl, C 1 -C 6 alkynyl, —CO 2 C 1 -C 6 alkyl, or —R 5 —NR′R″ wherein R 5 is C 1 -C 6 alkylene, C 1 -C 6 alkenylene or C 1 -C 6 alkynylene and R′ and R″ are each independently hydrogen, C 1 -C 6 alkyl or alternatively the group —NR′R″ as a whole is 1-pyrrolidinyl; and R 3 is hydrogen, nitro, amino, halogen, C 1 -C 6 alkoxy, hydroxy or C 1 -C 6 alkyl or a pharmaceutically acceptable salt thereof. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010068750-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103512972-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010068750-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020303073-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010310681-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9017735-B2 |
| priorityDate | 2004-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 555.